WCM Investment Management
IMVT icon

WCM Investment Management’s Immunovant IMVT Stock Holding History

WCM Investment Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-155,937
Closed -$2.86M – 253
2025
Q1 		$2.86M Sell
155,937
-3,588
-2% -$75.1K 0.01% 214
2024
Q4 		$3.81M Sell
159,525
-14,459
-8% -$410K 0.01% 200
2024
Q3 		$4.88M Sell
173,984
-1,558
-0.9% -$46K 0.01% 168
2024
Q2 		$4.56M Buy
175,542
+5,877
+3% +$167K 0.01% 165
2024
Q1 		$5.48M Buy
169,665
+62,264
+58% +$2.27M 0.01% 156
2023
Q4 		$4.55M Buy
+107,401
New +$3.95M 0.01% 170

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

WCM Investment Management's IMVT Position: Q2 2025 in Review

WCM Investment Management sold out of Immunovant (IMVT) in Q2 2025, closing a stake of 155,937 shares — an estimated $2.86M sold.

WCM Investment Management first reported a position in IMVT in Q4 2023 and held it in 6 quarters. The position peaked at $5.48M in Q1 2024. 168 funds tracked by Wall St. Rank hold IMVT as of Q2 2025.

  • WCM Investment Management reported no remaining Immunovant position as of Q2 2025 after selling out during the quarter.
  • WCM Investment Management sold 155,937 Immunovant shares in Q2 2025, an estimated $2.86M.
  • WCM Investment Management first reported a position in Immunovant in Q4 2023 and held it in 6 quarters.
  • WCM Investment Management's Immunovant position peaked at $5.48M in Q1 2024.
  • 168 funds tracked by Wall St. Rank held Immunovant as of Q2 2025.

Based on WCM Investment Management's 13F filing for Q2 2025, filed 29 Jul 2025.